Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2867_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
15 Мб
Скачать
☆
51 Primary Mucinous Adenocarcinoma of Renal Pelvis Misdiagnosed as Calculus…
371
nephrostomy (PCN). A considerable amount of gelatinous material was drained via a PCN catheter without urine. The catheter was blocked the second day, and PCN was performed again. However, these methods failed to curb the patient’s fever, and he was transferred to the hospital. Physical examination was generally normal except for percussion tenderness in the right kidney region. Laboratory tests dem­onstrated elevated red (20/μL) and white blood cells (200/μL) in the urinalysis, a decreased red blood cell count (4.29 × 1012/L) and hemoglobin concentration (118g/L), and elevated CEA (7.89ng/mL) and CA19-9 (5.79ng/mL). HBsAg was positive. Liver function, renal function, coagulation function, and stool routine examination were generally normal. Chest computed tomography scan showed an old tuberculosis scar on the right lung. The doctors suspected that he had gastroin­testinal cancer and performed an upper gastrointestinal endoscopy and a colonos­copy. However, nothing abnormal was found on the gastric or colonic mucosa, and the gelatinous material collected from the PCN catheter indicated no malignancy. Doctors diagnosed the patient with Calculus pyonephrosis and malignant tumor to be excluded. An open radical nephrectomy was then performed. His kidney was markedly enlarged with a thinning renal cortex. There was an unintentional spill­age of gelatinous material because of the two PCN procedures. Therefore, the doc­tors only performed a nephrectomy without a total ureterectomy. After opening the kidney, there were polypoids, gelatinous material, and stones lling the renal pel­vis. Histologically, the tumor was detected in intestinal metaplasia and glandular acini with multiple extracellular mucins. Immunohistochemistry revealed that tumor markers CDX2, CEA, villin, and ki67 (60%) were positive and tumor mark­ers CA125, MUC6, CK7, CD20, GATA3, S100P, and SATB2 were negative. The histologic diagnosis of primary mucinous adenocarcinoma of the renal pelvis was conducted. This patient was advised to undergo adjuvant chemotherapy because of the spillage of gelatinous material during surgery, but he refused. After 1 year of follow-up, the patient reported no discomfort, and a computed tomography scan indicated no sign of recurrence. Upon testing the serum tumor markers it indicated that CEA was 3.57ng/mL depicts a timeline of the diagnosis, interventions, and outcomes [1].

Differential Diagnosis

1. Calculus pyonephrosis—Calculus pyonephrosis and primary mucinous adeno­carcinoma of renal pelvis both drain mucinous material on PCN.Histopathological analysis can help differentiate calculus pyonephrosis from primary mucinous adenocarcinoma of the renal pelvis.
2. Ureteropelvic junction stenosis with stones in the renal pelvis—Urologist must consider a possibility of primary mucinous adenocarcinoma of renal pelvis in patients presenting with renal stones accompanied by severe hydronephrosis and chronic inammation.
372
M. M. J. Shaikh

Discussion

Mucinous adenocarcinoma is usually of colorectal and ovarian origin. It is charac­terized by abundant mucus production [2, 3]. As seen in the patient above, percuta­neous nephrostomy drained gelatinous material. Multiple renal pelvic calculi, stenosis of the ureter, and severe hydronephrosis were seen, along with cortical thinning. These features made it easy to diagnose Calculus pyonephrosis. PCN can also cause iatrogenic spillage and tumor cell seeding. It is essential to be cautious before conducting PCN for pyonephrosis and consider the possibility of malig­nancy. The most common presenting features are ank pain, hematuria, abdominal mass, and discomfort. All the features except for mass do not indicate malignancy. Out of all the total cases reported, it has been studied that only 20% of the cases showed elevated tumor marker CEA 19-9.
Plan ofAction, thePoints Clinician Should Consider, Pitfalls toAvoid, andPearls ofKnowledge toConsider
Taking careful history, physical examination, and measuring tumor marker levels accompanied by CT scans can improve the diagnosis accuracy rates. Primary ade­nocarcinoma of the renal pelvis or ureter is a rare entity. Urologists should always have a window of suspicion whenever mucinous material is seen on a nephrostomy tube. No standard treatment has been established so far. It has been studied for pelvis tumor nephroureterectomy with a bladder cuff accompanied by chemother­apy can improve the prognosis [7]. No surgical procedures have been proposed for this tumor yet. Only after a histopathological analysis, a denitive diagnosis of primary mucinous adenocarcinoma can be made [8]. Primary mucinous adenocar­cinoma has a lousy prognosis, and most of the patients die within 2–5years of follow-up [9].

Conclusion

Although on percutaneous nephrostomy, Calculus pyonephrosis and primary muci­nous adenocarcinoma drain gelatinous material, it is worth noting that it can be differentiated. Common clinical presentation of Mucinous Adenocarcinoma are ank pain and abdominal pain [10]. If the lesion bleeds when touched, it’s possibly a pelvic tumor, while a lesion in pyonephrosis does not bleed easily.
51 Primary Mucinous Adenocarcinoma of Renal Pelvis Misdiagnosed as Calculus…
373

References

1. Li H, Xie F, Zhao C, Yi Z, Chen J, Zu X.Primary mucinous adenocarcinoma of the renal pelvis misdiagnosed as calculous pyonephrosis: a case report and literature review. Transl Androl Urol. 2020;9(2):781.
2. Hugen N, Brown G, Glynne-Jones R, de Wilt JH, Nagtegaal ID. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol. 2016;13(6):361–9.
3. Morice P, Gouy S, Leary A.Mucinous ovarian carcinoma. N Engl J Med. 2019;380(13):1256–66.
4. Lai C, Teng XD.Primary enteric-type mucinous adenocarcinoma of the renal pelvis masquer­ading as cystic renal cell carcinoma: a case report and review of the literature. Pathol Res Pract. 2016;212(9):842–8.
5. Hasebe M, Serizawa S, Chino S. On a case of papillary cystadenocarcinoma following malignant degeneration of a papillary adenoma in the kidney pelvis. Yokohama Med Bull. 1960;11:491–500.
6. Sisodia SM, Khan WA, Bhavsar SP.Incidental primary papillary mucinous adenocarcinoma of the renal pelvis in a case of non-functioning kidney due to chronic pyelonephritis and pelvic calculus. Saudi J Kidney Dis Transpl. 2012;23:592–3.
7. Takehara K, Nomata K, Eguchi J, Hisamatsu H, Maruta S, Hayashi T, Koga S, Kanetake H.Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladder. Int J Urol. 2004;11(11):1016–8.
8. Lee HY, Jang MY, Wu WJ, Shen JT, Wang HS, Chang SF, Tsai KJ.Primary mucinous adeno­carcinoma of the renal pelvis. Urol Sci. 2014;25(2):65–7.
9. Ye YL, Bian J, Huang YP, Guo Y, Li ZX, Deng CH, Dai YP, Sun XZ.Primary mucinous adeno­carcinoma of the renal pelvis with elevated CEA and CA19-9. Urol Int. 2011;87(4):484–8.
10. Sidharth, Maskey P, Chalise PR, etal. Primary mucinous adenocarcinoma of the renal pelvis and ureter. Nepal Med Coll J. 2011;13:229–30.
Chapter 52
Kidney Inammatory Myobroblastic Tumor Misdiagnosed asaMetastatic Malignancy
MariaMohammedJavedShaikh
Learning Objectives
By the end of this presentation, the clinician will be able to:
1. Create an appropriate differential diagnosis in patients presenting with symp­toms of gross hematuria.
2. Evaluate clinical and radiological evidence to come up with a diagnosis of kid­ney inammatory myobroblastic tumor.
3. Conrm the diagnosis based on immunohistochemical and microscopic analyses.
4. Discuss the identication and early treatment of infectious causes of inamma­tory myobroblastic tumors of the kidney.
5. Emphasize the need for follow-up to prevent recurrence and metastasis.

Introduction

An inammatory myobroblastic tumor (IMT) is also called an inammatory pseu­dotumor. It is a mesenchymal tumor characterized by spindle cells from broblasts and inltration of different types of inammatory cells [1]. Only 48 cases of IMT have been reported so far from 1972 to 2019. The rst-ever case of IMT was reported in 1937. From the published databases, it was reviewed that out of a total of 48 cases, 37 occurred in the renal parenchyma, and the other 11 cases occurred in the renal pelvis. It occurs equally in both men and women. It can occur in a wide range of age groups from 3 to 75years old. It was found that 73% of the cases occurred in the age
M. M. J. Shaikh (*) St. Martinus University Faculty of Medicine, Willemstad, Curacao e-mail: maria.shaikh@martinus.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 H. Tohid et al. (eds.), The Misdiagnosis Casebook in Clinical Medicine,
https://doi.org/10.1007/978-3-031-28296-6_52
375
376
M. M. J. Shaikh
population over 40 years old. Only ve cases accounted for in children below 14years old. There is no sex predilection of this disease. The most common location of IMT is the lungs; extrapulmonary sites include the head, neck, liver, retroperito­neum, ventricles, bladder, and spinal canal [2–10]. In the genitourinary system, the most common site is the bladder [11]. The kidney is an unusual site for IMT.Fifty percent of cases involve the left kidney and the remaining 50% of the cases in the right kidney. IMT was notably found to be more commonly occurring in the upper pole of the kidney than in the lower pole. The literature suggests that spindle cell proliferation is reactive hyperplasia that occurs due to chronic inammation, surgery, or trauma. However, etiological factors are still unknown. Long- standing nephroli­thiasis is also suspected as one of the causes of IMT.IMT was initially thought to be an inammatory pseudotumor. However, later research classies this as a borderline neoplasm because it was found that spindle cells were the main part of these tumors [1]. As per a few scholars, IMT has been redened as low-grade neoplasm. It is cru­cial to identify these tumors and treat them as it has a potential for metastasis, is locally invasive, and can recur. It is challenging to diagnose it preoperatively because it is a rare entity involving the kidneys and is often missed by the physician and mis­diagnosed as a malignant disease both clinically and pathologically [4, 5]. It occurs equally in both men and women. It can occur in a wide range of age groups. It is more often diagnosed in children than adults of both sexes equally. However, extra­pulmonary forms occur more commonly in adult women [2]. Most commonly it clinically presents mainly as lower back pain and abdominal pain. Other clinical presentations include hematuria, anemia, recurrent high fever, abdominal discom­fort, lethargy, and weight loss. It can also be an incidental nding in imaging. The tumor size reviewed ranged from 1.5cm to 13.5cm. In clinical practice, the rst-line treatment is surgical resection of the lesion. In patients with bilateral masses, single kidney, or renal insufciency, a biopsy with intraoperative pathological assessment was highly suggested by some authors to avoid needless removal. However, it is still disputable as the diagnosis can be made only post nephrectomy [22]. It is linked to the anaplastic lymphoma kinase (ALK) gene, located on 2p53 in 50% of cases. Fusion partners are clathrin heavy chain, tropomyosin, and ran-binding protein, correction-genes that have been seen in patients who are ALK-positive. Fusion pro­teins involved with ALK-negative genes are reactive oxygen species (ROS-1) and platelet-derived growth factor (PDGF) genes [12, 13]. ALK-positive cases are more commonly found in children. Herein, we discuss a case of renal IMT in a patient with a history of long-standing nephrolithiasis to improve the understanding of the disease and impart the patients with better treatment and management.

Clinical Case Presentation

A 77-year-old female with a past medical history of bilateral renal calculus for 15years was admitted to the urology department. She complained of recurrent pain­less gross hematuria for 1 month. At the time, doctors treated her with cephalosporin, which was not effective. Computed tomography (CT) imaging showed a mixed
52 Kidney Inammatory Myobroblastic Tumor Misdiagnosed as a Metastatic…
density and slightly heterogeneous enhancement of the lesion in the middle pole of the left kidney and adrenal enlargement ipsilaterally. The patient underwent surgical treatment by retroperitoneoscopic left radical nephrectomy plus adrenalectomy. On microscopy, a large number of typical spindle cells surrounded by plasma cells and lymphocytes were observed. Immunohistochemical analyses indicated that these spindle cells were positive for vimentin, cytokeratin (CK), Ki-67, CK7, cluster of differentiation (CD) 34, and CD31 and focally positive for CD10 and anaplastic lymphoma kinase (ALK-1). So, a denitive diagnosis of IMT was made. The patient improved after the operation, and no recurrence or metastasis was noted during the 22-month follow-up. Laboratory investigation showed mild anemia and infection on routine blood work, with a hemoglobin level of 10.0g/dL and a leukocyte count of
12.2×109 cells/L.On urinalysis, it showed a large number of red blood cells. Other
laboratory results were within the normal limits, and no malignant cells were noted in three urine cytopathologic analyses. On imaging, only bilateral renal calculus was noted on abdominal ultrasound; however, no space-occupying lesions were noted. CT imaging showed a slightly heterogeneously enhancing mass in the middle pole of the left kidney and an ipsilateral adrenal enlargement, which was suspected as potential metastasis. Treatment-radical nephrectomy was performed retroperitoneo­scopically on the left kidney along with adrenalectomy [1].
377

Differential Diagnosis

1. Renal cell carcinoma—IMT is a benign tumor and has little potential for metas­tasis; however renal cell carcinoma can spread hematogenously.
2. Angiomyolipoma—Angiomyolipoma consists of fat and muscle cells; however, kidney IMT is composed of inammatory cells, spindle cells, and broblasts. Moreover, angiomyolipoma has been linked to TSC1 and TSC2 genes.
3. Xanthogranuloma—Xanthogranuloma is caused by chronic nephrolithiasis and infection. Biopsy will help differentiate xanthogranuloma from kidney IMT.

Discussion

IMT is a rare type of renal mesenchymal tumor composed mainly of spindle cells and various inammatory cells. It can occur in a wide range of age groups between 3 and 75years [7, 8]. Seventy-three percent of the cases reported were found in people 40years old. According to scholars, IMT can also be caused by Epstein-Barr virus [8]; others are found to be associated with hep B virus infection [9]. Etiological factors could be autoimmune or infectious. Some infectious causes with Mycobacterium tuberculosis and Eikenella corrodens have also been reported [14,
15]. IMT of kidneys does not have distinctive clinical and radiological features
making it difcult to diagnose. IMT in kidneys is slow-growing, occurring in middle- aged and elderly patients. It is usually conned to a single organ. It most
378
M. M. J. Shaikh
commonly manifests as pain and hematuria. A few cases presented with anemia, weight loss, fever, night sweats, and thrombocytosis, all of which resolved after treatment gradually. It is imperative to differentiate renal IMT from renal malignant disease. It lacks distinctive radiologic features, causing misinterpretation as a malig­nancy. It appears as hypoechoic and intratumoral vascular distribution on ultra­sound, making it difcult to differentiate from malignancy [16]. CT and magnetic resonance imaging (MRI) are better for the diagnosis of kidney masses. Cystic renal IMT should be differentiated from cystic renal cancer [17]. The conclusion diagno­sis usually depends on histopathological and immunohistochemical stains. On immunohistochemical stain, it usually appears as spindle cells with collagen, inl­trating lymphocytes, and plasma cells. The above case was misdiagnosed as malig­nant renal disease metastasized to the ipsilateral adrenal gland. In addition to surgery, chemotherapy should also be used as adjuvant therapy. Radiotherapy is mainly used in IMT involving the head and neck. It has been studied that high-dose fractionated radiotherapy is very effective for skull and nasopharyngeal IMT [18]. For ALK-positive cases, target therapy ALK inhibitors like crizotinib can be consid­ered [19]. For ALK-negative cases, nonsteroidal anti-inammatory drugs (NSAIDs) have been shown to reduce the tumor size and cure the disease [20]. Antibiotics can be used for infectious causes of IMT [21]. Corticosteroids are used in younger patients with bilateral renal IMT.Radiotherapy is an option when NSAIDs, steroids, and surgery fail to control IMT in the kidneys effectively.

Conclusion

The kidney is an unusual site for IMT neoplasm. Physicians need to be aware of the possibility of IMT in the differential diagnosis while evaluating renal masses to avoid misdiagnosis. Although IMT is not a malignant disease, it is reported to be associated with renal cell carcinoma, which should be considered in the manage­ment and prognosis of the patient. Surgery and adjuvant target and chemotherapy are considered to be rst-line treatments. As there is a possibility of recurrence and metastasis, follow-up is crucial.

References

1. Zhang GH, Guo XY, Liang GZ, Wang Q.Kidney inammatory myobroblastic tumor mas­querading as metastatic malignancy: a case report and literature review. World J Clin Cases. 2019;7(24):4366.
2. Attili SV, Chandra CR, Hemant DK, Bapsy PP, RamaRao C, Anupama G. Retroperitoneal inammatory myobroblastic tumor. World J Surg Oncol. 2005;3(1):1–4.
3. Shetty SJ, Pereira T, Desai RS.Inammatory myobroblastic tumor of the oral cavity: a case report and literature review. J Cancer Res Ther. 2019;15(3):725.
52 Kidney Inammatory Myobroblastic Tumor Misdiagnosed as a Metastatic…
4. Duan J, Wang Y.A case report of recurrent thyroid inammatory myobroblastic tumor and its metastasis in soft tissue. Medicine. 2017;96(45).
5. Na YS, Park SG.Inammatory myobroblastic tumor of the pleura with adjacent chest wall invasion and metastasis to the kidney: a case report. J Med Case Rep. 2018;12(1):1–5.
6. Wang S, Chen L, Cao Z, Mao X, Zhang L, Wang B.Inammatory myobroblastic tumor of the lumbar spinal canal: a case report with literature review. Medicine. 2017;96(26).
7. Heerwagen ST, Jensen C, Bagi P, Rappeport ED.Renal inammatory myobroblastic tumor: a rare tumor indistinguishable from renal cell carcinoma—report of two cases. Acta Radiol. 2007;48(10):1143–6.
8. Dogan MS, Doganay S, Koc G, Gorkem SB, Unal E, Ozturk F, Coskun A.Inammatory myo­broblastic tumor of the kidney and bilateral lung nodules in a child mimicking Wilms tumor with lung metastases. J Pediatr Hematol Oncol. 2015;37(6):e390–3.
9. You Y, Shao H, Bui K, Bui M, Klapman J, Cui Q, Coppola D. Epstein-Barr virus positive inammatory pseudotumor of the liver: report of a challenging case and review of the litera­ture. Ann Clin Lab Sci. 2014;44(4):489–98.
10. Li Z, Wang W, Wang Y, Zhai X, Tian Y, Fu Y, Zhou H. Inammatory myobroblastic tumor of the kidney with viral hepatitis B and trauma: a case report. Oncol Lett. 2013;6(6):1741–3.
11. Gwynn ES, Clark PE.Inammatory myobroblastic tumor associated with renal cell carci­noma. Urology. 2005;66(4):880–e7.
12. Surabhi VR, Chua S, Patel RP, Takahashi N, Lalwani N, Prasad SR.Inammatory myobro­blastic tumors: current update. Radiol Clin. 2016;54(3):553–63.
13. Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, Borinstein SC, Ross JS, Stephens PJ, Miller VA, Cofn CM. Inammatory myobroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014;4(8):889–95.
14. Liang W.A renal inammatory myobroblastic tumor similar to cystic renal cell carcinoma: one case report. Medicine. 2015;94(28).
15. Androulaki A, Papathomas TG, Liapis G, Papaconstantinou I, Gazouli M, Goutas N, Bramis K, Papalambros A, Lazaris AC, Papalambros E.Inammatory pseudotumor associated with mycobacterium tuberculosis infection. Int J Infect Dis. 2008;12(6):607–10.
16. Lee SH, Fang YC, Luo JP, Kuo HI, Chen HC.Inammatory pseudotumour associated with chronic persistent Eikenella corrodens infection: a case report and brief review. J Clin Pathol. 2003;56(11):868–70.
17. Ascenti G, Zimbaro G, Mazziotti S, Gaeta M, Lamberto S, Scribano E.Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol. 2001;11(12):2496–9.
18. Song D.Inammatory myobroblastic tumor of urinary bladder with severe hematuria: a case report and literature review. Medicine. 2019;98(1).
19. Gabel BC, Goolsby M, Hansen L.Inammatory myobroblastic tumor of the left sphenoid and cavernous sinus successfully treated with partial resection and high dose radiotherapy: case report and review of the literature. Cureus. 2015;20, 7(9)
20. Wu S, Xu R, Zhao H, Zhu X, Zhang L, Zhao X.Inammatory myobroblastic tumor of renal pelvis presenting with iterative hematuria and abdominal pain: a case report. Oncol Lett. 2015;10(6):3847–9.
21. Chavez C, Hoffman MA.Complete remission of ALK-negative plasma cell granuloma (inam­matory myobroblastic tumor) of the lung induced by celecoxib: a case report and review of the literature. Oncol Lett. 2013;5(5):1672–6.
22. Tazi K, Ehirchiou A, Karmouni T, Maazaz K, el Khadir K, Koutani A, Ibn Attiya AI, Hachimi M, Lakrissa A.Inammatory pseudotumors of the kidney: a case report. Ann Urol (Paris). 2001;35:30–3.
379
Part X
Neurology
Chapter 53
Guillain–Barré Syndrome Misdiagnosed asPosterior Circulation Stroke
JohnMichaelBaratta
Learning Objectives
By the end of this presentation, the clinician will be able to:
1. Demonstrate appropriate understanding of signs and symptoms of the condition that were presented in this case.
2. Enumerate the various diagnostic techniques to rule out the differential diagno­sis of this condition.
3. Discuss the various treatment modalities of this condition.
4. Describe the course of development of this condition by studying this case presentation.
5. Discuss the symptomatology of this condition.

Introduction

Guillain–Barré syndrome is an acute, demyelinating polyneuropathy which origi­nates through autoimmune mechanisms following an infectious illness [1]. It is most traditionally associated with sequelae of Campylobacter infection, although other triggers including a variety of infections and vaccinations have been impli­cated [2, 3]. Due to damage to the myelin of peripheral nerves, affected patients often develop bilateral, ascending weakness, sensory impairments, and loss of deep tendon reexes. While the course can progress insidiously, it is most concerning
J. M. Baratta (*) Department of Physical Medicine and Rehabilitation, Medical Director of Stroke Rehabilitation, University of North Carolina School of Medicine, Chapel Hill, NC, USA e-mail: john_baratta@med.unc.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 H. Tohid et al. (eds.), The Misdiagnosis Casebook in Clinical Medicine,
https://doi.org/10.1007/978-3-031-28296-6_53
383